Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Similar protein expression profiles of ovarian and endometrial high-grade serous carcinomas

18 Feb 2016

Abstract excerpt

BACKGROUND: Ovarian and endometrial high-grade serous carcinomas (HGSCs) have similar clinical and pathological characteristics; however, exhaustive protein expression profiling of these cancers has yet to be reported. METHODS: We performed protein expression profiling on 14 cases of HGSCs (7 ovarian and 7 endometrial) and 18 endometrioid carcinomas (9 ovarian and 9 endometrial) using iTRAQ-based exhaustive and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Proteomics Techniques and Applications
Share to Ferroptosis and cancer prognosis
Share to Ovarian cancer diagnosis and treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26889980
DOI: 10.1038/bjc.2016.27

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Similar protein expression profiles of ovarian and endometrial high-grade serous carcinomasPMID 26889980Read ↗

Proteomic characterization of epithelial ovarian cancer delineates molecular signatures and therapeutic targets in distinct histological subtypesSemantic proximity Read ↗

Differences in Gene Expression Between High- and Low-Grade Serous Ovarian Cancers: Implications for Diagnosis and PrognosisSemantic proximity Read ↗

Identification of Chemoresistance-Associated Key Genes and Pathways in High-Grade Serous Ovarian Cancer by Bioinformatics AnalysesSemantic proximity Read ↗

MUM1L1 as a Tumor Suppressor and Potential Biomarker in Ovarian Cancer: Evidence from Bioinformatics Analysis and Basic ExperimentsSemantic proximity Read ↗

Screening and identification of key genes between high-grade and low-grade serous ovarian carcinomas using integrated bioinformaticsSemantic proximity Read ↗

High Serpin Family A Member 10 Expression Confers Platinum Sensitivity and Is Associated With Survival Benefit in High-Grade Serous Ovarian Cancer: Based on Quantitative Proteomic AnalysisSemantic proximity Read ↗

Integration of histopathological images and multi-dimensional omics analyses predicts molecular features and prognosis in high-grade serous ovarian cancer.Semantic proximity Read ↗

Integrative proteomic profiling of ovarian cancer cell lines reveals precursor cell associated proteins and functional statusSemantic proximity Read ↗

TOP2A Promotes Tumorigenesis of High-grade Serous Ovarian Cancer by Regulating the TGF-β/Smad PathwaySemantic proximity Read ↗

Preneoplastic lesions fimbria pan-proteomic studies establish the fimbriectomy benefit for BRCA1/2 patients and identify early diagnosis markers of HGSCSemantic proximity Read ↗

Spatial Transcriptomic Analysis of Ovarian Cancer Precursors Reveals Reactivation of IGFBP2 during PathogenesisSemantic proximity Read ↗

Gene Expression Signatures Differentiate Ovarian/Peritoneal Serous Carcinoma from Diffuse Malignant Peritoneal MesotheliomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.